Doctors Note Logo

Published on: 9/28/2026

Steatosis of the Liver: What Fatty Liver on a Scan Means

Steatosis of the liver means an imaging scan such as ultrasound, CT, or MRI detected excess fat stored in your liver cells, a common finding that ranges from mild and reversible to more serious inflammation or scarring. Causes include metabolic factors like insulin resistance, obesity, high triglycerides, and type 2 diabetes, as well as alcohol use, certain medications, rapid weight loss, and some viral infections. Grading (mild, moderate, or severe) and follow-up tests like liver enzymes, FibroScan, or a fibrosis score determine whether the fat has progressed to steatohepatitis or fibrosis, and several important factors affect your risk, so see below to understand more.

Because fatty liver often causes no symptoms until damage advances, subtle signs such as fatigue, upper right abdominal discomfort, or unexplained weight changes are worth evaluating sooner rather than later. Take a free, instant, online symptom check to see how your symptoms and risk factors fit together and to get clear guidance on which next steps and specialists make sense for you.

Last reviewed for medical accuracy: 09/28/2026

answer background

Explanation

Steatosis of the Liver: What Fatty Liver on a Scan Means

Steatosis of liver—often called “fatty liver”—occurs when excess fat builds up in liver cells. It’s a common finding on ultrasound, CT or MRI scans. While mild steatosis of liver may cause no symptoms, understanding what it means and how to manage it can help protect long-term liver health.

What Is Steatosis of Liver?
Steatosis refers to fat droplets accumulating inside hepatocytes (liver cells). Normally, the liver contains a small amount of fat. When fat exceeds 5–10% of liver weight, it’s classified as steatosis. There are two main types:

  • Non-alcoholic fatty liver disease (NAFLD): Fat buildup not caused by heavy alcohol use. Commonly linked to obesity, diabetes, high cholesterol or certain medications.
  • Alcoholic fatty liver disease (AFLD): Fat accumulation due to excessive alcohol intake.

How Is Fatty Liver Detected?
Most people with steatosis of liver have no obvious signs. It’s usually picked up incidentally during imaging or routine blood tests. Detection methods include:

  • Ultrasound: Bright (“hyperechoic”) appearance of the liver.
  • CT scan: Lower density of liver tissue compared to spleen.
  • MRI: Quantifies liver fat more precisely.
  • Blood tests: Mildly elevated liver enzymes (ALT, AST), though normal levels don’t rule out steatosis.

Common Risk Factors
Several factors increase the risk of developing steatosis of liver:

  • Metabolic syndrome components:
    • Obesity (especially abdominal)
    • Insulin resistance or type 2 diabetes
    • High triglycerides, low HDL (“good”) cholesterol
    • High blood pressure
  • Excessive alcohol consumption (for AFLD)
  • Certain medications: corticosteroids, amiodarone, tamoxifen
  • Rapid weight loss or malnutrition
  • Genetic predisposition

Potential Symptoms and Complications
Most people with simple steatosis of liver feel well. However, some may notice:

  • Fatigue or mild discomfort in the upper right abdomen
  • Unexplained weight loss (rare)
    Over time, fat can trigger inflammation (steatohepatitis), leading to:
  • Fibrosis (scarring)
  • Cirrhosis (advanced scarring, impaired liver function)
  • Increased risk of liver cancer

It’s important to identify and address risk factors early to prevent progression.

Diagnosis and Assessment
After imaging suggests steatosis of liver, your doctor may recommend:

  • Blood work: liver enzymes, fasting glucose, lipid profile
  • Fibrosis assessment:
    • Non-invasive scores (Fibrosis-4, NAFLD fibrosis score)
    • Elastography (FibroScan) to measure liver stiffness
  • Rarely, liver biopsy to confirm inflammation and fibrosis stage

These tests help gauge whether simple fat accumulation has progressed to more serious injury.

Managing Steatosis of Liver
There’s no specific medication approved for reversing fatty liver. Management focuses on lifestyle changes and controlling underlying conditions:

  1. Lifestyle Modifications
    • Weight loss: A 5–10% reduction in body weight can significantly reduce liver fat.
    • Diet:
    – Emphasize fruits, vegetables, whole grains, lean proteins.
    – Limit added sugars, refined carbs, saturated fats.
    – Mediterranean-style diet shows benefit.
    • Exercise:
    – At least 150 minutes of moderate aerobic activity per week (brisk walking, cycling).
    – Strength training twice weekly.
    • Alcohol:
    – Avoid or limit intake. Even moderate drinking may worsen liver health.

  2. Medical Management
    • Control diabetes, high blood pressure, high cholesterol.
    • Statins and antidiabetic drugs (e.g., pioglitazone, GLP-1 agonists) may help in select cases—discuss options with your doctor.

  3. Regular Monitoring
    • Repeat liver enzyme tests every 6–12 months.
    • Follow-up imaging or elastography if fibrosis risk is high.

When to Seek Help
Steatosis of liver itself rarely causes emergencies. But worsening liver health can lead to serious complications. Seek medical attention if you experience:

  • Jaundice (yellowing of skin or eyes)
  • Unexplained swelling in legs or abdomen
  • Confusion or changes in alertness
  • Severe abdominal pain

If symptoms seem life threatening or progress rapidly, call emergency services immediately.

Preventing Progression
Early intervention can halt or reverse liver fat accumulation:

  • Maintain a healthy weight and waist circumference.
  • Keep blood sugar and lipids within target ranges.
  • Adopt consistent, balanced eating and exercise habits.
  • Review medications with your doctor; some drugs can increase steatosis risk.
  • Get routine health checkups, including liver function tests.

Considering Your Symptoms
If you’ve noticed fatigue, unexplained discomfort, or have risk factors for steatosis of liver, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you understand possible causes of your symptoms and guide you toward next steps.

Living Well with Steatosis of Liver
Most people with early steatosis of liver lead full, active lives. Key strategies for long-term health:

  • Build a support network—family, friends, support groups.
  • Set realistic goals: small, sustainable changes beat extreme diets.
  • Track progress: use apps or journals to monitor weight, diet and exercise.
  • Stay informed: look for credible resources (medical associations, peer-reviewed journals).

When to Talk to Your Doctor
Always consult a healthcare provider for personalized advice. Discuss any new or worsening symptoms, treatment side effects, or questions about medications. If you suspect serious liver problems—or any life-threatening condition—seek medical attention without delay.

Summary
Steatosis of liver means fat buildup in liver cells. It’s often silent but can progress to inflammation, fibrosis and cirrhosis. Early detection through imaging and blood tests, combined with lifestyle changes and management of related conditions, can reverse or stabilize liver health. Regular monitoring and collaboration with your healthcare team are essential.

Remember: if you have concerns about steatosis of liver or related symptoms, talking to a doctor is the best way to get clear guidance and peace of mind.

(References)

  • * Sherer DM, Abramowicz JS. Magnetic resonance imaging and computed tomography scan for the diagnosis of acute fatty liver in pregnancy. Am J Perinatol. 1992 Jul;9(4):311. PMID: 1627228.

  • * Chudácek Z. [Focal steatosis]. Bildgebung. 1990;57(1-2):32-4. PMID: 2271812.

  • * CAMAIN R, ROUILLER C, DUPIN H. [Development of hepatic steatosis in kwashiorkor treated by hyperprotein diet; simple & electron microscopic study]. Ann Anat Pathol (Paris). 1959 Apr-Jun;4(2):220-41. PMID: 13650240.

  • * Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2013 Dec;19(4):325-48. doi: 10.3350/cmh.2013.19.4.325. Epub 2013 Dec 28. PMID: 24459637; PMCID: PMC3894432.

  • * Walker AP. Ischaemic stroke and liver fibrosis. Atherosclerosis. 2017 May;260:153-155. doi: 10.1016/j.atherosclerosis.2017.03.028. Epub 2017 Mar 22. PMID: 28359541.

  • * Yang M, Hara AK, Nguyen BD, Roarke MC. Concurrent focal fat sparing and peritumoral fat sparing in diffuse fatty liver identified on 18F-FDG PETCT and multiparametric magnetic resonance imaging. Dig Liver Dis. 2017 Oct;49(10):1164. doi: 10.1016/j.dld.2017.04.019. Epub 2017 May 27. PMID: 28600027.

  • * Schaapman JJ, Coenraad MJ, Lamb HJ. Response to letter: Multiparametric magnetic resonance imaging in patients with nonalcoholic fatty liver disease. J Magn Reson Imaging. 2021 Jun;53(6):1941. doi: 10.1002/jmri.27510. Epub 2021 Jan 12. PMID: 33438298.

  • * Chen SQ, He K, Xiao XL. Multifocal nodular fatty infiltration of the liver: A donut-shaped appearance. Clin Res Hepatol Gastroenterol. 2022 Aug-Sep;46(7):101985. doi: 10.1016/j.clinre.2022.101985. Epub 2022 Jun 21. PMID: 35738358.

  • * Meria A, Meria P. Re: What Is the Prevalence of Hepatic Steatosis on Ultrasonography in Patients Followed for Nephrolithiasis? Eur Urol. 2023 Sep;84(3):352-353. doi: 10.1016/j.eururo.2023.05.007. Epub 2023 May 22. PMID: 37225527.

  • * Tokcan M, Hohl M, Schneider CV, Schneider KM, Markwirth P, Bernhard B, Haring B, Lauder L, Schattenberg J, Mahfoud F, Kulenthiran S, Böhm M. Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic Syndrome. Hypertension. 2026 Apr;83(4):e26601. doi: 10.1161/HYPERTENSIONAHA.125.26601. Epub 2026 Feb 24. PMID: 41732855; PMCID: PMC13001895.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.